Home-based Gait and Balance Training in Patients With Movement Disorders
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorForschungszentrum Juelich
About this trial
The research project is an experimental study with three study visits at the study site at the University Hospital Düsseldorf (UKD) / Heinrich Heine University Düsseldorf (HHU) and a three-week training phase in a parallel design. Patients with movement disorders (ataxia or Parkinson\'s disease) can take part. The training phase includes individually adapted, targeted, video-based coordination and balance training, which should lead to an improvement in gait and balance. Two different training protocols are carried out in parallel for three weeks each: One with 20 minutes of training per day, four days per week; and one with a training duration of 40 minutes per day, only two days per week. All patients initially take part in a one-week familiarization phase without training and are then randomly assigned to one of the two training protocols or the control group without additional training. In both training phases, the total amount of weekly training time is the same, but the frequency and duration of training sessions per week differs. The patients who were assigned to the control group without additional training can complete the training after their third study visit.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
clinical diagnosis of cerebellar ataxia or idiopathic Parkinson's syndrome
opportunity to walk a distance of four meters unhindered at home
Disqualifiers
other diseases with an impact on motor skills
severe primary psychiatric illnesses
current drug or alcohol addiction
consumptive diseases
Trial design
Design model
Parallel
Treatments tested in this trial
Gait and balance training
Other interventionThe training includes individually adapted, targeted, video-based coordination and balance training, which should lead to an improvement in gait and balance. It includes strength, coordination and flexibility exercises.
Treatment groups
80 Participants
are divided into 3 treatment groupsGroup A: 4 x 20 minutes training per weekExperimental treatment 1 intervention
Group B: 2 x 40 minutes training per weekExperimental treatment 1 intervention
Group C: control groupNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
gait velocity
measured in m/s, measured by a force plate (zebris), a motion capturing system (Xsens) and individual smartphones of the participants at week 0, at baseline (week 1), after training or no training (week 4) and after training for the control group (week 7).
Time frame
From enrollment to the end of intervention at 4 weeks (training groups) / at 7 weeks (control groups)Secondary outcomes
1
stride time
time needed for one stride (two steps) measured in s, measured by a force plate (zebris), a motion capturing system (Xsens) and individual smartphones of the participants at week 0, at baseline (week 1), after training or no training (week 4) and after training for the control group (week 7).
Time frame
From enrollment to the end of intervention at 4 weeks (training groups) / at 7 weeks (control groups)2
step width
measured in cm, measured by a force plate (zebris), a motion capturing system (Xsens) and individual smartphones of the participants at week 0, at baseline (week 1), after training or no training (week 4) and after training for the control group (week 7).
Time frame
From enrollment to the end of intervention at 4 weeks (training groups) / at 7 weeks (control groups)3
cadence
number of steps per second, measured in s\^-1, measured by a force plate (zebris), a motion capturing system (Xsens) and individual smartphones of the participants at week 0, at baseline (week 1), after training or no training (week 4) and after training for the control group (week 7).
Time frame
From enrollment to the end of intervention at 4 weeks (training groups) / at 7 weeks (control groups)4
Lat Step Dev
Lateral Step Deviation / step width variability (SD / CV), measured in cm, measured by a force plate (zebris), a motion capturing system (Xsens) and individual smartphones of the participants at week 0, at baseline (week 1), after training or no training (week 4) and after training for the control group (week 7).
Time frame
From enrollment to the end of intervention at 4 weeks (training groups) / at 7 weeks (control groups)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Forschungszentrum Juelich
Lead sponsor
Heinrich-Heine University, Duesseldorf
Collaborator
Source ClinicalTrials.gov